DK11992D0 - Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse - Google Patents

Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse

Info

Publication number
DK11992D0
DK11992D0 DK92119A DK11992A DK11992D0 DK 11992 D0 DK11992 D0 DK 11992D0 DK 92119 A DK92119 A DK 92119A DK 11992 A DK11992 A DK 11992A DK 11992 D0 DK11992 D0 DK 11992D0
Authority
DK
Denmark
Prior art keywords
epipodophyllotoxinglycoside
preparation
phosphate derivatives
phosphate
derivatives
Prior art date
Application number
DK92119A
Other languages
English (en)
Other versions
DK11992A (da
Inventor
Mark G Saulnier
Peter D Senter
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK11992A publication Critical patent/DK11992A/da
Publication of DK11992D0 publication Critical patent/DK11992D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
DK92119A 1987-08-04 1992-01-31 Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse DK11992D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (2)

Publication Number Publication Date
DK11992A DK11992A (da) 1992-01-31
DK11992D0 true DK11992D0 (da) 1992-01-31

Family

ID=26765636

Family Applications (2)

Application Number Title Priority Date Filing Date
DK434088A DK169344B1 (da) 1987-08-04 1988-08-03 Epipodophyllotoxinglucosid-4'-phosphatderivater, deres anvendelse til fremstilling af antitumormidler, en fremgangsmåde til fremstilling af derivaterne samt farmaceutiske præparater indeholdende disse
DK92119A DK11992D0 (da) 1987-08-04 1992-01-31 Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK434088A DK169344B1 (da) 1987-08-04 1988-08-03 Epipodophyllotoxinglucosid-4'-phosphatderivater, deres anvendelse til fremstilling af antitumormidler, en fremgangsmåde til fremstilling af derivaterne samt farmaceutiske præparater indeholdende disse

Country Status (34)

Country Link
US (3) US4904768A (da)
JP (1) JPH0699465B2 (da)
KR (1) KR900006230B1 (da)
CN (1) CN1027169C (da)
AT (1) AT398974B (da)
BE (1) BE1002982A4 (da)
CA (1) CA1310637C (da)
CH (1) CH676716A5 (da)
CY (1) CY1625A (da)
CZ (1) CZ286893B6 (da)
DD (2) DD274423A5 (da)
DE (1) DE3826562A1 (da)
DK (2) DK169344B1 (da)
ES (1) ES2010775A6 (da)
FI (1) FI87790C (da)
FR (1) FR2622193B1 (da)
GB (1) GB2207674B (da)
GR (1) GR1000490B (da)
HK (1) HK6392A (da)
HU (3) HU202547B (da)
IE (1) IE61040B1 (da)
IL (1) IL87290A (da)
IT (1) IT1226825B (da)
LU (2) LU87290A1 (da)
MX (1) MX173843B (da)
MY (1) MY104321A (da)
NL (2) NL192683C (da)
NO (4) NO170284C (da)
NZ (1) NZ225615A (da)
PT (1) PT88186B (da)
SE (1) SE502214C2 (da)
SG (1) SG101291G (da)
SK (1) SK279325B6 (da)
YU (3) YU143688A (da)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (da) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
CA2085520C (en) * 1991-12-23 1996-07-16 Uday Shankar Gogate Stable hexahydrate of etoposide 4'-phosphate disodium salt
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
WO1996040886A1 (en) * 1995-06-07 1996-12-19 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
NZ331629A (en) 1996-04-01 2000-04-28 Epix Medical Inc Bioactivated diagnostic imaging contrast agents
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
AP2003002831A0 (en) * 2001-10-26 2003-09-30 Centre Nat Rech Scient Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
ES2358730T3 (es) 2002-07-15 2011-05-13 Board Of Regents, The University Of Texas System Anticuerpos seleccionados y péptidos de duramicina que se enlazan a fosfolípidos aniónicos y aminofosfolípidos y sus usos en el tratamiento de infecciones virales y del cáncer.
SI1583562T1 (sl) * 2003-01-06 2011-10-28 Angiochem Inc AngioPep-1, sorodne spojine in njihove uporabe
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
ES2383901T5 (es) * 2005-02-18 2015-02-25 Angiochem Inc. Polipéptidos de aprotinina para transportar un compuesto a través de la barrera sangre-cerebro
CN101262890B (zh) * 2005-07-15 2015-08-26 安吉奥化学公司 抑肽酶多肽作为载体在药物缀合物中的用途
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
AR060358A1 (es) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic Quinazolinas para la inhibicion de pdk 1
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2009036106A1 (en) * 2007-09-13 2009-03-19 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
WO2009060198A1 (en) 2007-11-09 2009-05-14 Peregrine Pharmaceuticals, Inc. Anti-vegf antibody compositions and methods
JP2011506560A (ja) 2007-12-20 2011-03-03 ノバルティス アーゲー Ｐｉ３キナーゼ阻害剤として用いられるチアゾール誘導体
RU2518240C2 (ru) * 2008-04-18 2014-06-10 Ангиочем Инк. Композиция, на основе гидрофобных агентов и способ ее получения(варианты)
JP2012505637A (ja) 2008-10-15 2012-03-08 アンジオケム，インコーポレーテッド Ｇｌｐ−１アゴニストのコンジュゲート及びその使用
BRPI0920121A2 (pt) 2008-10-15 2019-09-24 Angiochem Inc conjugados de etoposida e doxorubicina para liberação de fármaco
JP5759379B2 (ja) * 2008-12-05 2015-08-05 アンジオケム インコーポレーテッド ニューロテンシンまたはニューロテンシンアナログおよびその使用
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
WO2010121379A1 (en) 2009-04-20 2010-10-28 Angiochem Inc Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
AU2010268726A1 (en) 2009-07-02 2012-01-19 Angiochem Inc. Multimeric peptide conjugates and uses thereof
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
CA2786294A1 (en) 2010-02-22 2011-08-25 F. Hoffmann-La Roche Ag Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
US8987257B2 (en) 2011-01-31 2015-03-24 Novartis Ag Heterocyclic derivatives
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
EP2771342B1 (en) 2011-10-28 2016-05-18 Novartis AG Purine derivatives and their use in the treatment of disease
CA2855994A1 (en) * 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
US10213432B2 (en) 2012-05-16 2019-02-26 Novartis Ag Dosage regimen for a PI-3 kinase inhibitor
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
PL3076969T3 (pl) 2013-12-06 2022-01-17 Novartis Ag Schemat dawkowania selektywnego inhibitora 3-kinazy fosfatydynozytolu alfa-izoformy
CA2989400A1 (en) 2015-06-15 2016-12-22 Angiochem Inc. Ang1005 for the treatment of leptomeningeal carcinomatosis
CA3002954A1 (en) 2015-11-02 2017-05-11 Novartis Ag Dosage regimen for a phosphatidylinositol 3-kinase inhibitor
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (da) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH481094A (de) * 1966-12-13 1969-11-15 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd ４′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
USRE35524E (en) 1997-06-03
SG101291G (en) 1992-01-17
DK169344B1 (da) 1994-10-10
YU143688A (en) 1990-04-30
NO170284C (no) 1992-09-30
HU211960A9 (en) 1996-01-29
NL970042I2 (da) 2005-06-01
SE8802815L (sv) 1989-02-05
DK11992A (da) 1992-01-31
NO920665L (no) 1989-02-24
MX9202851A (es) 1992-06-30
FR2622193A1 (fr) 1989-04-28
ES2010775A6 (es) 1989-12-01
FI87790B (fi) 1992-11-13
NO920665D0 (no) 1992-02-20
US5041424A (en) 1991-08-20
CY1625A (en) 1992-07-10
GB8818462D0 (en) 1988-09-07
DE3826562C2 (da) 1993-04-08
SE502214C2 (sv) 1995-09-18
FI883596A (fi) 1989-02-05
NO920277D0 (no) 1992-01-22
HUT47303A (en) 1989-02-28
PT88186A (pt) 1989-06-30
HU208147B (en) 1993-08-30
IT1226825B (it) 1991-02-19
SK541288A3 (en) 1998-10-07
NO883299D0 (no) 1988-07-26
NO170284B (no) 1992-06-22
DE3826562A1 (de) 1989-02-16
FR2622193B1 (fr) 1993-12-17
LU87290A1 (fr) 1990-02-07
IE882378L (en) 1989-02-04
AT398974B (de) 1995-02-27
NL970042I1 (nl) 1998-03-02
DD299067A5 (de) 1992-03-26
AU610619B2 (en) 1991-05-23
SE8802815D0 (sv) 1988-08-03
NO1998002I1 (no) 1998-01-14
US4904768A (en) 1990-02-27
CZ541288A3 (cs) 1999-12-15
GR1000490B (el) 1992-07-30
HU202547B (en) 1991-03-28
IT8821535A0 (it) 1988-07-28
CA1310637C (en) 1992-11-24
NO883299L (no) 1989-02-24
FI883596A0 (fi) 1988-08-01
NZ225615A (en) 1991-06-25
KR900006230B1 (ko) 1990-08-27
DK434088A (da) 1989-02-05
MX173843B (es) 1994-03-30
YU10390A (en) 1990-06-30
YU10490A (en) 1990-06-30
GR880100512A (en) 1989-05-25
BE1002982A4 (fr) 1991-10-15
GB2207674A (en) 1989-02-08
JPH01100188A (ja) 1989-04-18
IE61040B1 (en) 1994-09-07
DD274423A5 (de) 1989-12-20
FI87790C (fi) 1993-02-25
MY104321A (en) 1994-03-31
JPH0699465B2 (ja) 1994-12-07
IL87290A (en) 1993-01-31
SK279325B6 (sk) 1998-10-07
CZ286893B6 (cs) 2000-07-12
GB2207674B (en) 1991-09-11
HU905862D0 (en) 1991-03-28
IL87290A0 (en) 1989-01-31
CN1027169C (zh) 1994-12-28
NO172440C (no) 1993-07-21
HK6392A (en) 1992-01-17
PT88186B (pt) 1995-07-03
AU2030688A (en) 1989-06-08
CH676716A5 (da) 1991-02-28
ATA195588A (de) 1994-07-15
NO172440B (no) 1993-04-13
CN1061225A (zh) 1992-05-20
NL192683B (da) 1997-08-01
LU90138I2 (fr) 1997-11-26
NO920277L (no) 1989-02-24
DK434088D0 (da) 1988-08-03
KR890003790A (ko) 1989-04-18
NL8801934A (nl) 1989-03-01
NL192683C (nl) 1997-12-02

Similar Documents

Publication Publication Date Title
DK11992A (da) Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse
DK374289D0 (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK605489D0 (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
DK570089D0 (da) 2'-halogenmethyliden-, 2'-ethenyliden- og 2'-ethynyl-cytidin-, -uridin- og -guanosin-derivater, deres fremstilling og anvendelse
DK131787D0 (da) 1,1-disubstituerede cyclopropanderivater, deres fremstilling og anvendelse
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
DK193088D0 (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK473289A (da) 2'-halogenmethyliden-, 2'-ethenyliden- og 2'-ethynyl-adenosin-derivater, deres fremstilling og anvendelse
DK633287D0 (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK293888D0 (da) Fenolderivater og deres fremstilling og anvendelse
DK191988A (da) Pyrrolidin-2-(1,3-dicarbonyl)-derivater, deres fresmtilling og anvendelse
DK278188D0 (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK235787A (da) Tripeptidderivater, deres fremstilling og anvendelse
DK189488A (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK213387D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK212687A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK223288D0 (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK610787D0 (da) Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse
DK412188D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK231988A (da) 2-aminoalkyl-4-benzyl-1-(2h)-phthalazinon-derivater, deres fremstilling og anvendelse
DK613888D0 (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK361388A (da) Cephemderivater, deres fremstilling og anvendelse
DK668788A (da) Labdanderivater, deres fremstilling og anvendelse
DK668888A (da) Labdan-derivater, deres fremstilling og anvendelse
DK455189D0 (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment